Loading...
Header Logo
Keywords
Last Name
Institution

UME L. ABBAS

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Infectious Disease
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular Virology & Microbiology
    DivisionMolecular Virology & Microbiology


    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    R21AI064092     (ABBAS, UME L)Jun 15, 2005 - May 31, 2008
    NIH/NIAID
    Impact of Antiretrovirals on the Spread of HIV
    Role: Principal Investigator

    R21AI078789     (ABBAS, UME L)Sep 25, 2008 - Aug 31, 2011
    NIH/NIAID
    Impact of ARV Chemoprophylaxis on Emergence and Spread of HIV Drug Resistance
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pallotta AM, Pirzada SA, Shrestha RK, Yen-Lieberman B, Calabrese LH, Taege AJ, Butler RS, Abbas UL. Presentation to HIV care and antiretroviral therapy initiation and response in clinical practice from 2003 through 2013. Int J STD AIDS. 2019 Aug; 30(9):853-860. PMID: 31280687.
      View in: PubMed
    2. Abbas UL, Glaubius RL, Ding Y, Hood G. Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study. PLoS One. 2019; 14(7):e0218649. PMID: 31269034.
      View in: PubMed
    3. Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, Parikh UM, Abbas UL. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness. J Int AIDS Soc. 2019 May; 22(5):e25282. PMID: 31074936.
      View in: PubMed
    4. Glaubius RL, Parikh UM, Hood G, Penrose KJ, Bendavid E, Mellors JW, Abbas UL. Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention. Open Forum Infect Dis. 2016 Sep; 3(3):ofw125. PMID: 27703992.
      View in: PubMed
    5. Glaubius RL, Hood G, Penrose KJ, Parikh UM, Mellors JW, Bendavid E, Abbas UL. Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa. Clin Infect Dis. 2016 08 15; 63(4):539-47. PMID: 27193745.
      View in: PubMed
    6. van de Vijver DA, Nichols BE, Abbas UL, Boucher CA, Cambiano V, Eaton JW, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff KC, Hallett TB. Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models. AIDS. 2013 Nov 28; 27(18):2943-51. PMID: 23939237.
      View in: PubMed
    7. Abbas UL, Glaubius R, Hood G, Mellors JW. Antiretroviral treatment, preexposure prophylaxis, and drug resistance in sub-Saharan Africa: a consensus among mathematical models. J Infect Dis. 2014 Jan 01; 209(1):164-6. PMID: 24133186.
      View in: PubMed
    8. Abbas UL, Glaubius R, Mubayi A, Hood G, Mellors JW. Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa. J Infect Dis. 2013 Jul 15; 208(2):224-34. PMID: 23570850.
      View in: PubMed
    9. Abbas UL, Hood G, Wetzel AW, Mellors JW. Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP). PLoS One. 2011 Apr 15; 6(4):e18165. PMID: 21525976.
      View in: PubMed
    10. Abbas UL. Uptake of biomedical interventions for prevention of sexually transmitted HIV. Curr Opin HIV AIDS. 2011 Mar; 6(2):114-8. PMID: 21505385.
      View in: PubMed
    11. Abbas UL, Anderson RM, Mellors JW. Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS One. 2007 Sep 19; 2(9):e875. PMID: 17878928.
      View in: PubMed
    12. Abbas UL, Anderson RM, Mellors JW. Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. J Acquir Immune Defic Syndr. 2006 Apr 15; 41(5):632-41. PMID: 16652038.
      View in: PubMed
    13. Friedman CP, Abbas UL. Is medical informatics a mature science? A review of measurement practice in outcome studies of clinical systems. Int J Med Inform. 2003 Mar; 69(2-3):261-72. PMID: 12810129.
      View in: PubMed
    14. Abbas UL, Mellors JW. Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward. Proc Natl Acad Sci U S A. 2002 Oct 15; 99(21):13377-8. PMID: 12370421.
      View in: PubMed
    ABBAS's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description